The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 23, 2022
Filed:
May. 10, 2019
Applicant:
Sunovion Pharmaceuticals Inc., Marlborough, MA (US);
Inventors:
Nathan John Bryson, Toronto, CA;
Anthony John Giovinazzo, Caledon, CA;
Scott David Barnhart, York, PA (US);
Michael Clinton Koons, York, PA (US);
Assignee:
Sunovion Pharmaceuticals Inc., Marlborough, MA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4415 (2006.01); A61K 9/00 (2006.01); A61K 47/38 (2006.01); A61K 31/485 (2006.01); A61P 25/16 (2006.01); A61K 9/70 (2006.01); A61F 13/00 (2006.01); A61K 47/02 (2006.01); A61K 47/14 (2017.01); A61K 31/4045 (2006.01); A61K 31/473 (2006.01); A61K 45/06 (2006.01); A61K 31/381 (2006.01); A61K 31/428 (2006.01); A61K 31/48 (2006.01); A61K 31/4985 (2006.01); A61K 31/506 (2006.01); A61J 1/03 (2006.01); A61J 7/00 (2006.01); B29C 39/18 (2006.01); B65D 65/38 (2006.01); A61K 47/10 (2017.01); A61K 47/12 (2006.01); A61K 47/22 (2006.01); A61K 47/36 (2006.01); B29C 39/38 (2006.01); B29C 43/30 (2006.01); B29C 43/52 (2006.01); B29C 65/70 (2006.01); B29C 65/00 (2006.01); A61K 9/24 (2006.01); B29K 1/00 (2006.01); B29L 31/00 (2006.01); B29L 7/00 (2006.01); B29L 9/00 (2006.01);
U.S. Cl.
CPC ...
A61F 13/00063 (2013.01); A61J 1/03 (2013.01); A61J 7/0053 (2013.01); A61K 9/006 (2013.01); A61K 9/7007 (2013.01); A61K 31/381 (2013.01); A61K 31/4045 (2013.01); A61K 31/428 (2013.01); A61K 31/4415 (2013.01); A61K 31/473 (2013.01); A61K 31/48 (2013.01); A61K 31/485 (2013.01); A61K 31/4985 (2013.01); A61K 31/506 (2013.01); A61K 45/06 (2013.01); A61K 47/02 (2013.01); A61K 47/10 (2013.01); A61K 47/12 (2013.01); A61K 47/14 (2013.01); A61K 47/22 (2013.01); A61K 47/36 (2013.01); A61K 47/38 (2013.01); A61P 25/16 (2018.01); B29C 39/18 (2013.01); B29C 39/38 (2013.01); B29C 43/305 (2013.01); B29C 43/52 (2013.01); B29C 65/70 (2013.01); B29C 66/45 (2013.01); B65D 65/38 (2013.01); A61K 9/209 (2013.01); A61K 2300/00 (2013.01); B29K 2001/00 (2013.01); B29L 2007/008 (2013.01); B29L 2009/00 (2013.01); B29L 2031/753 (2013.01); B29L 2031/755 (2013.01);
Abstract
The invention features sublingual film formulations of dopamine agonists and methods of treating Parkinson's disease, tremors, restless leg syndrome, sexual dysfunction, and depressive disorders therewith.